Biotech Stock Soars 194% on Licensing Deal 🚀

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Welcome to the Closing Bell Roundup. Please, feel free to reply to this email and tell us what you think of this new addition to the Elite Trade Club lineup! It's Tuesday, December 6th. I hope you had a great day! Here's what moved the market today: Markets 📈 It was another down day for the market as interest rate concerns continued to weigh on investor sentiment. The Dow [-1.0%], S&P 500 [-1.4%], and Nasdaq [-2.0%] suffered notable declines, and the small-cap Russell 2K [-1.5%] also took sharp losses. Sponsored [The Biggest Opportunity in the EV Market ⚡]( You may know of graphite as what's in the tip of a No. 2 pencil, but this humble mineral is also at the epicenter of the electric car revolution. Most people don't know that today's EV batteries contain more than 220 pounds of graphite - more than lithium, copper or aluminum! One tiny company could corner the domestic graphite market, and, if they do, it could mean enormous growth for their bottom line. Now's the time to get an early jump on this up-and-coming industry. [Get the Stock's Ticker Here]( Today's Market-Moving News 🔎 📉 Trade Gap Widens: The US trade deficit increased to $78.2 billion in October from $74.1 billion in September. US exports fell by 0.7%. 🛢 Tanker Jam: The newly-passed price cap on Russian oil is creating chaos in global supply chains, including a tanker traffic jam that's forming in the Turkish Straits, a vital global shipping lane. Today's Top Winners and Losers 🔥 Gossamer Bio [GOSS] $2.36 (-74.6%) Gossamer Bio's Phase 2 study of seralutinib in pulmonary arterial hypertension patients met its primary endpoint, but the experimental drug produced an inordinately high rate of emergent adverse events. Barnes & Noble Education [BNED] $1.85 (-27.4%) Barnes & Noble Education's reported disappointing Q2 earnings results. Its earnings & sales figures fell well short of analyst estimates. Herbalife [HLF ://elitetra.de/L2Ic ] $13.06 (-25.4%) On Monday afternoon, Herbalife announced plans for a private offering of $250 million worth of senior convertible notes. The deal also includes a purchaser option for another $37.5 million in notes. Summit Therapeutics [SMMT] $2.31 (+194.2%) Summit Therapeutics landed a licensing deal with China-based Akeso Inc [AKESF] for its revolutionary cancer therapy ivonescimab. Summit paid $500 million upfront in exchange for the rights to develop & commercialize ivonescimab in the US, Canada, Europe, & Japan, and the deal could ultimately pay out as much as $5 billion in royalties and milestones. Pacifico Acquisition [PAFO] $8.03 (+59.0%) On Monday evening, news broke that shareholders voted to approved Pacifico Acquisition SPAC's proposed merger with Caravelle Inc. Eterna Therapeutics [ERNA] $4.46 (+43.8%) A Form 4 filing from today revealed that an Eterna insider, 10%+ owner John D Halpern, purchased another 335,920 shares at a price of about $1.1 million. News of the big insider buy sent shares higher in today's session. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](